Please login to the form below
publish
This page shows the latest publish news and features for those working in and with pharma, biotech and healthcare.
UK government commissions independent review into clinical trials
O’Shaughnessy is set to publish his advice this spring, which will include actions that can be taken to make progress in 2023, as well as longer-term ambitions for UK
Latest news
-
NICE publishes final draft guidance recommending three COVID-19 treatments
The medicines have shown promise in treating COVID-19 and been found cost-effective
-
NHS urges people yet to receive their COVID-19 booster to come forward
illness, with the committee set to publish further advice in due course.
-
Europe’s cancer community publishes new report on transforming patient care
The guide comes as the European Commission is preparing to publish the revision of the pharmaceutical legislation, with the report urging policy makers to commit to five areas when making key
-
WHO publishes brief calling for integrated approach to epilepsy treatment
Epilepsy affects over 50 million people globally and accounts for 125,000 death per year
-
NICE publishes draft guidance recommending three COVID-19 treatments
Five treatments have not been recommended for use, with the organisation citing cost-effectiveness concerns
More from news
Approximately 0 fully matching, plus 240 partially matching documents found.
Latest Intelligence
-
Every superhero has an origin story – what’s yours?
Ethical considerations surrounding phase 1 studies. There is also an ethical obligation to publish data from all studies conducted in humans.
-
Bombarded with information – the challenge of crowded digital channels
Companies have a duty to publish the information within 12 months of the study – but this is typically considered an obligation rather than an opportunity.
-
Persuasive technology: designing behaviour change initiatives for digital
EPG Health has utilised such psychology in combination with 360-degree stakeholder research and a Gartner leading technology suite to design, build and publish its new medical website ‘Medthority’.
-
Industry needs an aligned position on the future of the EU OMP Regulation
As part of this overarching approach, which includes measures to keep the EU at the leading edge of innovation, including in healthcare, the Commission is expected to publish a Pharmaceutical Strategy
-
Can marketing change the world?
What we ended up doing was actually building a partnership with YouTube to help our creators natively publish their videos to YouTube, Facebook, LinkedIn and Twitter,” she told Forbes Women’s
More from intelligence
Approximately 0 fully matching, plus 34 partially matching documents found.
Latest appointments
-
Emotive grows medical writing capacity
Her career to date has seen her publish several clinical papers over the past three years and she has been involved in various ageing awareness activities.
-
NHiS appoints mental health associate director
During this time, he has worked closely with local authorities to publish the Merton Mental Health Needs Assessment and helped to develop the Alzheimer's Society's Dementia Hub.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
COUCH Health publishes report to encourage patient engagement in the MedTech sector
Manchester, UK, 27 February 2023 — COUCH Health today announced the publication of a new report “The Power of Patient Engagement in MedTech”. The report was conducted and produced by the COUCH Health in-house research team, who spoke to
-
Winter and workforce woes: challenges facing the new Secretary of State for Health and Social Care
During the brief, ill-fated Truss administration, government’s only intervention of note on the NHS was to publish a winter plan.
-
A new 10-year cancer plan: Will the government be able to deliver what the sector needs?
Nobody is under the illusion that solving the ingrained workforce problems will be easy, but we can start to take steps to have a future demand-led strategy, routinely publish workforce
-
Digital Opinion Leaders (DOLs): Who are they and how can Pharma engage them?
When you think about traditional Key Opinion Leaders (KOLs), you likely picture established physicians who are well-known and admired in their fields, publish regularly, attend and speak at major conferences,
-
EQUAL FOOTING: HOW PHARMA CAN HELP THE NHS TO ACT ON HEALTH INEQUALITIES
Underpinning this, Integrated Care Boards (ICBs) are required to create a five-year plan, which should set out how they will exercise this duty and will also need to publish an ... year plan and, to some extent, the one-year service delivery plans that
More from PMHub
Approximately 1 fully matching, plus 32 partially matching documents found.
Subscribe to our email news alerts
-
Senior Medical Writer
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Ketchum appoints Conor Nash as global chief financial officer and chief operating officer
PMHub
IGNIFI
We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
